Overview

A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.

Status:
Completed

Trial end date:
2016-08-10

Target enrollment:

Participant gender:

Summary

In this comparative bioavailability and in vivo skin adhesion study, the impact of minor changes in qualitative composition of polyiso-Butylenes (PIB) from a different supplier and change of the manufacturing line of the micro porous membrane will be tested.

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Butylscopolammonium Bromide
Scopolamine
Scopolamine Hydrobromide